Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.03 new
Vol. 5, Issue 4 (2016)

Endogenous insulin and glucose concentration in patients with paranoid schizophrenia treated with atypical antipsychotics

Author(s):
I.R. Romash
Abstract:
The article presents the results of the investigation of changes in endogenous insulin indices and glucose level in blood serum during prolonged treatment (3 months) with atypical antipsychotics. Increase in both indices was observed in the studied groups. The index of endogenous insulin concentration significantly increased by 10.9% and constituted 17.56±0.70 uIU/mL (p<0.05) and glucose level in blood serum increased by 36.6% and amounted 7.01±0.29 mmol/L (p<0.05). Long-term risperidone use caused significant increase in insulin concentration by 19.3% up to the level of 19.85±1.50 uIU/mL (p<0.05) and increase in fasting glycemia by 34.5% reaching 8.44±0.23 mmol/L (p<0.05). Treatment with quetiron during 3 months caused a significant increase in insulin concentration in blood serum by 2.96% from 15.05±1.73 uIU/mL to 15.49±0.69 uIU/mL (p<0.05) as well as a significant increase in glycemia level by 20.3% from 5.39±0.78 to 6.76±0.27 mmol/L (p<0.05).
Pages: 43-45  |  602 Views  12 Downloads
How to cite this article:
I.R. Romash. Endogenous insulin and glucose concentration in patients with paranoid schizophrenia treated with atypical antipsychotics. 2016; 5(4): 43-45.
Journals List Click Here Research Journals Research Journals
Call for book chapter